ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Resverlogix Corp

Resverlogix Corp (RVX)

0.055
0.00
(0.00%)
Closed December 26 4:12PM

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
0.055
Bid
0.05
Ask
0.055
Volume
248,000
0.05 Day's Range 0.055
0.04 52 Week Range 0.095
Market Cap
Previous Close
0.055
Open
0.055
Last Trade
1000
@
0.055
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
63,538
Shares Outstanding
272,371,000
Dividend Yield
-
PE Ratio
-0.81
Earnings Per Share (EPS)
-0.06
Revenue
57k
Net Profit
-16.74M

About Resverlogix Corp

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Headquarters
Calgary, Alberta, Can
Founded
-
Resverlogix Corp is listed in the Biological Pds,ex Diagnstics sector of the Toronto Stock Exchange with ticker RVX. The last closing price for Resverlogix was $0.06. Over the last year, Resverlogix shares have traded in a share price range of $ 0.04 to $ 0.095.

Resverlogix currently has 272,371,000 shares outstanding. The market capitalization of Resverlogix is $14.98 million. Resverlogix has a price to earnings ratio (PE ratio) of -0.81.

RVX Latest News

InvestmentPitch Media Video Discusses Resverlogix and its Focus on Apabetalone’s Future Development for the Prevention and Treatment of Post COVID-19 Conditions

VANCOUVER, British Columbia, Sept. 30, 2022 (GLOBE NEWSWIRE) -- Resverlogix Corp. (TSX:RVX) (OTCPink:RVXCF), a world leader in epigenetics, or gene regulation, announced that apabetalone’s...

Resverlogix Confirms Focus on Treatment of Post COVID-19 Conditions

CALGARY, Alberta, Sept. 28, 2022 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix" or the “Company”) (TSX:RVX) today announced that apabetalone’s future clinical development related to...

Resverlogix Publishes New Data Highlighting Apabetalone’s Benefit in Non-alcoholic Fatty Liver Disease

CALGARY, Alberta, Aug. 22, 2022 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix") (TSX:RVX) today announced the publication of an article entitled “Reduction in the Risk of Major Adverse...

Resverlogix Announces Appointment of New Chief Scientific Officer

CALGARY, Alberta, Aug. 15, 2022 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix") (TSX:RVX) today announced the appointment of Dr. Ewelina Kulikowski, Ph.D. as Chief Scientific Officer. Dr...

Resverlogix Announces Voting Results from the 2022 Meeting of Shareholders

CALGARY, Alberta, June 21, 2022 (GLOBE NEWSWIRE) -- Resverlogix Corp. (“Resverlogix”, or the "Corporation") (TSX:RVX) today held its Annual Meeting of Shareholders (the “Meeting”) in Calgary...

Resverlogix Announces New Research Findings Highlighting the Safety of BD2-selective BET Inhibitors

CALGARY, Alberta, June 08, 2022 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix") (TSX:RVX) today announced the publication of an article entitled “Breaking boundaries: Pan BETi disrupt 3D...

Resverlogix Announces Type C Meeting with FDA for CORAL, a Phase 3 High-risk COVID-19 Outpatient Study

CALGARY, Alberta, May 09, 2022 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix", or "the Company") (TSX:RVX), in partnership with EVERSANA™, today announced that the U.S. Food and Drug...

Resverlogix Announces One-Year Extension of Debenture

CALGARY, Alberta, April 19, 2022 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix" or the “Company”) (TSX:RVX) announced today that it has closed a one-year extension of Company’s US$6.0...

Apabetalone’s Positive Impact on Pulmonary Arterial Hypertension Published in the American Journal of Respiratory and Critical Care Medicine

CALGARY, Alberta, March 17, 2022 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix") (TSX:RVX) today announced the publication of an article entitled “BET Protein Inhibition for Pulmonary...

Resverlogix Corp. to Webcast Live at VirtualInvestorConferences.com March 10th

CALGARY, Alberta, March 09, 2022 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix") (TSX:RVX), a global leader in the development of epigenetic therapeutics, today announced that Donald...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1000.0550.060.05813880.055CS
4-0.005-8.333333333330.060.060.05882840.05681243CS
120.005100.050.070.05635380.05940941CS
260.005100.050.0950.04796550.0669737CS
52-0.015-21.42857142860.070.0950.04575160.06547205CS
156-0.515-90.3508771930.570.820.04676490.17469086CS
260-1.145-95.41666666671.21.530.04645800.43922439CS

RVX - Frequently Asked Questions (FAQ)

What is the current Resverlogix share price?
The current share price of Resverlogix is $ 0.055
How many Resverlogix shares are in issue?
Resverlogix has 272,371,000 shares in issue
What is the market cap of Resverlogix?
The market capitalisation of Resverlogix is CAD 14.98M
What is the 1 year trading range for Resverlogix share price?
Resverlogix has traded in the range of $ 0.04 to $ 0.095 during the past year
What is the PE ratio of Resverlogix?
The price to earnings ratio of Resverlogix is -0.81
What is the cash to sales ratio of Resverlogix?
The cash to sales ratio of Resverlogix is 250
What is the reporting currency for Resverlogix?
Resverlogix reports financial results in USD
What is the latest annual turnover for Resverlogix?
The latest annual turnover of Resverlogix is USD 57k
What is the latest annual profit for Resverlogix?
The latest annual profit of Resverlogix is USD -16.74M
What is the registered address of Resverlogix?
The registered address for Resverlogix is 4820 RICHARD ROAD S.W, SUITE 300, CALGARY, ALBERTA, T3E 6L1
What is the Resverlogix website address?
The website address for Resverlogix is www.resverlogix.com
Which industry sector does Resverlogix operate in?
Resverlogix operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
GMTNGold Mountain Mining Corp
$ 0.035
(16.67%)
10k
XLYAuxly Cannabis Group Inc
$ 0.035
(16.67%)
378.93k
PPRPrairie Provident Resources Inc
$ 0.035
(16.67%)
390k
WRXWestern Resources Corp
$ 0.04
(14.29%)
3k
GFRGreenfire Resources Ltd
$ 10.09
(13.37%)
31.9k
RTGRTG Mining Inc
$ 0.025
(-37.50%)
100k
NCFNorthcliff Resources Ltd
$ 0.02
(-20.00%)
1.03M
KLSKelso Technologies Inc
$ 0.11
(-15.38%)
3.5k
AVLAvalon Advanced Materials Inc
$ 0.035
(-12.50%)
114k
YRBYorbeau Resources Inc
$ 0.035
(-12.50%)
110k
TTelus Corp
$ 19.45
(-1.52%)
4.87M
BBBlackBerry Limited
$ 5.65
(4.05%)
3.61M
ABXBarrick Gold Corporation
$ 22.55
(0.71%)
3.57M
BITFBitfarms Ltd
$ 2.45
(6.06%)
3.26M
FCUFission Uranium Corp
$ 0.72
(-2.70%)
2.54M